Brain-Training Exercises for Long COVID
Trial Summary
Will I have to stop taking my current medications?
The trial requires that if you are on psychiatric medications, you must be on a stable dose for at least 1 month before starting the study and have no plans to change the dose during the study.
What data supports the effectiveness of the treatment NeuroFlex for Long COVID?
Research on brain-training exercises, similar to NeuroFlex, shows they can improve cognitive and functional symptoms in people with traumatic brain injuries and seniors, suggesting potential benefits for Long COVID. Additionally, noninvasive brain stimulation techniques have shown early success in improving symptoms like brain fog and mood in Long COVID patients.12345
Is the brain-training exercise NeuroFlex safe for humans?
The research does not provide specific safety data for NeuroFlex or similar brain-training exercises, but related interventions like progressive muscle relaxation and cognitive training have been studied for mental health and cognitive benefits in COVID-19 patients without reported safety concerns.678910
How does the treatment NeuroFlex for Long COVID differ from other treatments?
What is the purpose of this trial?
This trial is testing if computerized brain-training exercises can help older adults with Long COVID. The goal is to see if these exercises can improve thinking, mood, and daily activities. The study will check if the exercises are easy to use and if they actually help.
Research Team
Cutter Lindbergh, Ph.D.
Principal Investigator
UConn Health
Eligibility Criteria
This trial is for older adults (55+) who've had COVID-19 and are experiencing ongoing cognitive symptoms that started after their illness. They should be fluent in English, have a certain level of cognitive function (TICS ≥ 27), and not planning to change any psychiatric medication doses during the study. People with neurological disorders, prior cognitive impairments unrelated to COVID-19, significant psychiatric conditions, recent substance use disorders, or major sensory/motor issues can't participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo computerized brain-training exercises to treat Long COVID symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- NeuroFlex
Find a Clinic Near You
Who Is Running the Clinical Trial?
UConn Health
Lead Sponsor
National Institute on Aging (NIA)
Collaborator